Why Y Matters? The Implication of Loss of Y Chromosome in Blood and Cancer

Overview

Journal Cancer Sci

Specialty Oncology

Date 2024 Jan 23

PMID 38258457

Authors

Ying Wang

Soichi Sano

Affiliations

Soon will be listed here.

Abstract

Hematopoietic mosaic loss of Y chromosome (mLOY) has emerged as a potential male-specific accelerator of biological aging, increasing the risk of various age-related diseases, including cancer. Importantly, mLOY is not confined to hematopoietic cells; its presence has also been observed in nonhematological cancer cells, with the impact of this presence previously unknown. Recent studies have revealed that, whether occurring in leukocytes or cancer cells, mLOY plays a role in promoting the development of an immunosuppressive tumor microenvironment. This occurs through the modulation of tumor-infiltrating immune cells, ultimately enabling cancer cells to evade the vigilant immune system. In this review, we illuminate recent progress concerning the effects of hematopoietic mLOY and cancer mLOY on cancer progression. Examining cancer progression from the perspective of LOY adds a new layer to our understanding of cancer immunity, promising insights that hold the potential to identify innovative and potent immunotherapy targets for cancer.

Citing Articles

Sex differences in disease: sex chromosome and immunity.

Feng Z, Liao M, Zhang L J Transl Med. 2024; 22(1):1150.

PMID: 39731171 PMC: 11673612. DOI: 10.1186/s12967-024-05990-2.

Selective loss of Y chromosomes in lung adenocarcinoma modulates the tumor immune environment through cancer/testis antigens.

Fischer J, Shutta K, Chen C, Fanfani V, Saha E, Mandros P bioRxiv. 2024; .

PMID: 39345481 PMC: 11430018. DOI: 10.1101/2024.09.19.613876.

The impact of mosaic loss of the Y chromosome (mLOY) in men of advanced age.

Abou Abdallah F, Abdel Massih C, Attieh C, Chebly A Biogerontology. 2024; 25(6):943-955.

PMID: 39223433 DOI: 10.1007/s10522-024-10133-7.

Mosaic variegated aneuploidy in development, ageing and cancer.

Malumbres M, Villarroya-Beltri C Nat Rev Genet. 2024; 25(12):864-878.

PMID: 39169218 DOI: 10.1038/s41576-024-00762-6.

Loss of the Y Chromosome: A Review of Molecular Mechanisms, Age Inference, and Implications for Men's Health.

Gutierrez-Hurtado I, Sanchez-Mendez A, Becerra-Loaiza D, Rangel-Villalobos H, Torres-Carrillo N, Gallegos-Arreola M Int J Mol Sci. 2024; 25(8).

PMID: 38673816 PMC: 11050192. DOI: 10.3390/ijms25084230.

References

Repping S, van Daalen S, Brown L, Korver C, Lange J, Marszalek J . High mutation rates have driven extensive structural polymorphism among human Y chromosomes. Nat Genet. 2006; 38(4):463-7. DOI: 10.1038/ng1754. View

Cortopassi G . A neutral theory predicts multigenic aging and increased concentrations of deleterious mutations on the mitochondrial and Y chromosomes. Free Radic Biol Med. 2002; 33(5):605-10. DOI: 10.1016/s0891-5849(02)00966-8. View

Qi M, Pang J, Mitsiades I, Lane A, Rheinbay E . Loss of chromosome Y in primary tumors. Cell. 2023; . DOI: 10.1016/j.cell.2023.06.006. View

Komura K, Jeong S, Hinohara K, Qu F, Wang X, Hiraki M . Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression. Proc Natl Acad Sci U S A. 2016; 113(22):6259-64. PMC: 4896695. DOI: 10.1073/pnas.1600420113. View

Thompson D, Genovese G, Halvardson J, Ulirsch J, Wright D, Terao C . Genetic predisposition to mosaic Y chromosome loss in blood. Nature. 2019; 575(7784):652-657. PMC: 6887549. DOI: 10.1038/s41586-019-1765-3. View

Loftfield E, Zhou W, Yeager M, Chanock S, Freedman N, Machiela M . Mosaic Y Loss Is Moderately Associated with Solid Tumor Risk. Cancer Res. 2018; 79(3):461-466. PMC: 6359954. DOI: 10.1158/0008-5472.CAN-18-2566. View

Nadal M, Pera G, Pujadas J, Abril J, Gonzalez L, Aguilo F . Aneuploidy of chromosome Y in prostate tumors and seminal vesicles: a possible sign of aging rather than an indicator of carcinogenesis?. Mol Carcinog. 2007; 46(7):543-52. DOI: 10.1002/mc.20301. View

Godfrey A, Naqvi S, Chmatal L, Chick J, Mitchell R, Gygi S . Quantitative analysis of Y-Chromosome gene expression across 36 human tissues. Genome Res. 2020; 30(6):860-873. PMC: 7370882. DOI: 10.1101/gr.261248.120. View

Zhou W, Machiela M, Freedman N, Rothman N, Malats N, Dagnall C . Mosaic loss of chromosome Y is associated with common variation near TCL1A. Nat Genet. 2016; 48(5):563-8. PMC: 4848121. DOI: 10.1038/ng.3545. View

10.

Forsberg L, Rasi C, Malmqvist N, Davies H, Pasupulati S, Pakalapati G . Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer. Nat Genet. 2014; 46(6):624-8. PMC: 5536222. DOI: 10.1038/ng.2966. View

11.

Abdel-Hafiz H, Schafer J, Chen X, Xiao T, Gauntner T, Li Z . Y chromosome loss in cancer drives growth by evasion of adaptive immunity. Nature. 2023; 619(7970):624-631. PMC: 10975863. DOI: 10.1038/s41586-023-06234-x. View

12.

Bachtrog D . The temporal dynamics of processes underlying Y chromosome degeneration. Genetics. 2008; 179(3):1513-25. PMC: 2475751. DOI: 10.1534/genetics.107.084012. View

13.

Rice W . Degeneration of a nonrecombining chromosome. Science. 1994; 263(5144):230-2. DOI: 10.1126/science.8284674. View

14.

Ler L, Ghosh S, Chai X, Thike A, Heng H, Siew E . Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2. Sci Transl Med. 2017; 9(378). DOI: 10.1126/scitranslmed.aai8312. View

15.

Wojcik M, Juhas U, Mohammadi E, Mattisson J, Drezek-Chyla K, Rychlicka-Buniowska E . Loss of Y in regulatory T lymphocytes in the tumor micro-environment of primary colorectal cancers and liver metastases. Sci Rep. 2024; 14(1):9458. PMC: 11043399. DOI: 10.1038/s41598-024-60049-y. View

16.

Duan Q, Gao Y, Cao X, Wang S, Xu M, Jones O . Mosaic loss of chromosome Y in peripheral blood cells is associated with age-related macular degeneration in men. Cell Biosci. 2022; 12(1):73. PMC: 9153148. DOI: 10.1186/s13578-022-00811-9. View

17.

Forsberg L, Halvardson J, Rychlicka-Buniowska E, Danielsson M, Moghadam B, Mattisson J . Mosaic loss of chromosome Y in leukocytes matters. Nat Genet. 2018; 51(1):4-7. DOI: 10.1038/s41588-018-0267-9. View

18.

Hughes J, Skaletsky H, Brown L, Pyntikova T, Graves T, Fulton R . Strict evolutionary conservation followed rapid gene loss on human and rhesus Y chromosomes. Nature. 2012; 483(7387):82-6. PMC: 3292678. DOI: 10.1038/nature10843. View

19.

Bachtrog D . Y-chromosome evolution: emerging insights into processes of Y-chromosome degeneration. Nat Rev Genet. 2013; 14(2):113-24. PMC: 4120474. DOI: 10.1038/nrg3366. View

20.

Wang Y, Sano S . Why Y matters? The implication of loss of Y chromosome in blood and cancer. Cancer Sci. 2024; 115(3):706-714. PMC: 10921008. DOI: 10.1111/cas.16072. View